Beta-adrenergic receptor polymorphism in human cardiovascular disease

Annals of Medicine

Volumn 36, Issue SUPPL. 1, 2004, Pages 64-69

  Leineweber, Kirsten ^a  

^a UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

Author keywords

adrenoceptors; Genotype; Haplotype; Linkage disequilibrium; Phenotype; Single nucleotide polymorphism

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; ADRENALIN; ARGININE; ATENOLOL; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; DOBUTAMINE; GLUTAMINE; GLYCINE; ISOLEUCINE; ISOPRENALINE; METOPROLOL; NORADRENALIN; PROPRANOLOL; SERINE; TERBUTALINE; THREONINE;

CARDIOVASCULAR DISEASE; CONFERENCE PAPER; DISEASE COURSE; DOWN REGULATION; EX VIVO STUDY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; IN VITRO STUDY; IN VIVO CULTURE; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR BINDING; RISK FACTOR;

ANIMALS; CARDIOVASCULAR DISEASES; CELL LINE; HAPLOTYPES; HUMANS; PHENOTYPE; POLYMORPHISM, GENETIC; PROGNOSIS; RECEPTORS, ADRENERGIC, BETA; VARIATION (GENETICS);

EID: 2442692712     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.1080/17431380410032544     Document Type: Conference Paper

References (44)

1. Johnson JA, Terra SG. β-Adrenergic receptor polymorphisms: cardiovascular disease associations and pharmacogenetics. Pharm Res 2002;19:1779-87.
2. 1-adrenergic receptor affect agonist-promoted trafficking. J Cardiovasc Pharmacol 2002; 39:155-60.
3. 1-adrenergic receptor. J Biol Chem 1999;74:12670-4.
4. 1-adrenoceptors in isolated human atrial myocardium. Br J Pharmacol 2003;138:386-92.
5. 1-adrenergic receptor polymorphisms in human right atrium in vitro. J Am Coll Cardiol 2002;40:1275-82.
6. 1-adrenergic receptor gene polymorphism and human fat cell lipolysis. Int J Obesity 2001;25:1599-603.
7. 1-adrenoceptor polymorphism varies in frequency among different ethic groups but does not alter response in vivo. Pharmacogenetics 2001;11:191-7.
8. 1-adrenoceptor polymorphism in humans. Pharmacogenetics 2001;11:199-205.
9. Dishy V, Sofowora G, Xie HG, Harris P, Wood AJJ, Stein CM. Arg389Gly beta-1 adrenoceptor polymorphism does not affect agonist-mediated responses in vivo. Clin Pharmacol Ther 2001;69:P5 (abstract).
10. 1-Adrenozeptors: Unterschiedliche Effekte von Metoprolol in Abhängigkeit vom Genotyp. Z Kardiol 2003;92 (Suppl):I/191 (abstract).
11. 1-adrenoceptor does not influence blood pressure or heart rate response to β-blockade in hypertensive subjects. Clin Sci 2000;99:233-8.
12. 1-padrenergic receptor polymorphism (Arg389Gly) affects blood pressure response to β-blockade. Clin Pharmacol Ther 2003;73:366-71.
13. 1-adrenoceptor genetic polymorphisms on resting hemodynamics in patients undergoing diagnostic testing for ischemia. Am J Cardiol 2001;88: 1034-7.
14. 1-adrenergic receptor gene and hypertension. Circulation 2001; 104:187-90.
15. 1-adrenoceptor gene and evaluation of its role in idiopathic dilated cardiomyopathy. J Mol Cell Cardiol 1999;31:1025-32.
16. 1-Adrenoceptor gene variations: a role in idiopathic dilated cardiomyopathy? J Mol Med 2000;78:87-93.
17. Iwai C, Akita H, Shiga N, Takai E, Miyamoto Y, Shimizu M, et al. Suppressive effect of the Gly389 allele of the beta1-adrenergic receptor gene on the occurrence of ventricular tachycardia in dilated cardiomyopathy. Circ J 2002;66:723-8.
18. 2C-adrenergic receptors and the risk of congestive heart failure. N Engl J Med 2002;347:1135-42.
19. White HL, Maqbool A, McMahon AD, Yates L, Ball SG, Hall AS, et al. An evaluation of the beta-1 adrenergic receptor ARg389Gly polymorphism in individuales at risk of coronary events. A WOSCOPS substudy. Eur Heart J 2002;23:1087-92.
20. Kanki H, Yang P, Xie HG, Kim RB, George AL, Jr, Roden DM. Polymorphisms in beta-adrenergic receptor genes in the acquired long QT syndrome. J Cardiovasc Electrophysiol 2002;13:252-6.
21. 1-adrenergic receptor associated with survival in patients with heart failure. Eur Heart J 2000;21:1853-8.
22. McNamara DM, MacGowan GA, London B. Clinical importance of b-adrenoceptor polymorphisms in cardiovascular disease. Am J Pharmacogenomics 2002;2:73-8.
23. 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J Biol Chem 1993;268: 23116-21.
24. 5. Eur J Pharmacol 2001;421:141-7.
25. 2-adrenergic receptor polymorphisms adversely affects the outcome of congestive heart failure. J Clin Invest 1998;102:1534-9.
26. 2-adrenergic receptor polymorphism expressed in transgenic mice. Proc Natl Acad Sci USA 1996;93: 10483-8.
27. 2-adrenoceptors. Circulation 2001; 103:1048-50.
28. 2 adrenoceptor gene Thr164Ile polymorphism on human adipose tissue lipolytic function. Br J Pharmacol 2001;133:708-12.
29. 2-adrenoceptor exhibits blunted desensitization of cardiac functional responses in vivo. Am J Physiol Heart Circ Physiol 2003. Jul 17 [online 10.1152/ajpheart.00324.2003].
30. 2-adrenergic receptor down-regulation. Clin Pharmacol Ther 2003;74:255-63.
31. 2-adrenoceptor polymorphism slows the onset of desensitization of cardiac functional responses in vivo. Pharmacogenetics 2003;13:59-66.
32. Gratze G, Fortin J, Labugger R, Binder A, Kotanko P, Timmermann B, et al. Beta-2 adrenergic receptor variants affect resting blood pessure and agonist-induced vasodilation in young adult Caucasians. Hypertension 1999;33:1425-30.
33. Hoit BD, Suresh DP, Craft L, Walsh RA, Liggett SB. Beta2-adrenergic receptor polymorphisms at amino acid 16 differentially influence agonist-stimulated blood pressure and peripheral blood flow in normal individuals. Am Heart J 2000;139:537-42.
34. 2-Adrenoceptor polymorphism determines vascular reactivity in humans. Hypertension 2000;36:371-5.
35. Dishy V, Sofowora GG, Xie HG, Kim RB, Byrne DW, Stein CM, et al. The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization. N Engl J Med 2001;345:1030-5.
36. 2-Adrenergic receptor polymorphism and nitric oxide-dependent forearm blood flow responses to isoproterenol in humans. J Physiol 2003;546.2:583-9.
37. 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 1994;33:9414-9.
38. 2-adrenergic receptor and asthma. Am J Respir Crit Care Med 1997;156:S156-62.
39. 2 adrenoceptor polymorphism is associated with elevated immunglobulin E levels in asthmatic families. J Allergy Clin Immunol 1997;100:261-5.
40. 2-adrenergic receptor polymorphisms: No association with essential hypertension in black and white Americans. Clin Pharmacol Ther 2000;67:670-5.
41. 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci USA 2000;97:10483-8.
42. 2-Adrenergic receptor gene variation and hypertension in subjects with type 2 diabetes. Hypertension 2001;37:1303-8.
43. Fenech A, Hall IP. Pharmacogenetics of asthma. Br J Clin Pharmacol 2001;53:3-15.
44. Joos L, Sandford AJ. Genotype predictors of response to asthma medications. Curr Opin Pulm Med 2002;8:9-15.